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Abstract: Brucellosis is a debilitating zoonotic disease that affects humans and animals. The diagnosis
of brucellosis is challenging, as accurate species level identification is not possible with any of the
currently available serology-based diagnostic methods. The present study aimed at identifying
Brucella (B.) species-specific proteins from the closely related species B. abortus and B. melitensis
using sera collected from naturally infected host species. Unlike earlier reported investigations
with either laboratory-grown species or vaccine strains, in the present study, field strains were
utilized for analysis. The label-free quantitative proteomic analysis of the naturally isolated strains
of these two closely related species revealed 402 differentially expressed proteins, among which
63 and 103 proteins were found exclusively in the whole cell extracts of B. abortus and B. melitensis
field strains, respectively. The sera from four different naturally infected host species, i.e., cattle,
buffalo, sheep, and goat were applied to identify the immune-binding protein spots present in
the whole protein extracts from the isolated B. abortus and B. melitensis field strains and resolved
on two-dimensional gel electrophoresis. Comprehensive analysis revealed that 25 proteins of
B. abortus and 20 proteins of B. melitensis were distinctly immunoreactive. Dihydrodipicolinate
synthase, glyceraldehyde-3-phosphate dehydrogenase and lactate/malate dehydrogenase from
B. abortus, amino acid ABC transporter substrate-binding protein from B. melitensis and
fumarylacetoacetate hydrolase from both species were reactive with the sera of all the tested naturally
infected host species. The identified proteins could be used for the design of serological assays
capable of detecting pan-Brucella, B. abortus- and B. melitensis-specific antibodies.
Keywords: Brucella; host specificity; mass spectrometry; Liquid chromatography–mass spectrometry
(LC-MS); two dimensional electrophoresis; 2D-PAGE; Matrix-assisted laser desorption/
ionization-Tine of Flight-Mass Spectrometry MALDI-TOF MS; proteomics; Western blot
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1. Introduction
Brucellosis is a zoonosis affecting a wide range of mammals including humans [1]. The genus
Brucella currently includes 12 accepted nomo-species, with Brucella (B.) abortus and B. melitensis
representing the species in the majority of notified human cases. These two species possess strikingly
similar genomes [2] but display differences in host specificity and their proteomes [3]. B. melitensis
is the most virulent species of all brucellae, one of the major causes of abortions in small ruminants
and the causative agent of severe infections in humans [4]. B. abortus infections occur in cattle while
infections in small ruminants and camels are rare [5]. In humans the course of B. abortus infections is
milder [4].
The conventional methods for species identification include cultivation, as well as genome-based
assays [6]. All these methods are hazardous, time-consuming and not suitable for ‘high-throughput
analysis’; moreover, the routinely utilized bacterial lipopolysaccharide (LPS)-based serological
methods are hampered by cross-reactivity with the LPS of other Gram-negative bacteria such as
Yersinia enterocolitica, Salmonella spp, and Escherichia coli O:157 [7]. Furthermore, serological tests cannot
distinguish between B. abortus and B. melitensis infection or between naturally infected and vaccinated
animals [8,9].
The aim of this study was to identify B. abortus- and B. melitensis-specific proteins reacting with
circulating antibodies in naturally infected animal host species. This immunoblot-based approach
identified several immunodominant proteins from B. abortus and B. melitensis, which could be used to
design a new diagnostic brucellosis assay.
2. Results
2.1. Comparative Proteomics Analysis of Brucella (B.) abortus and B. melitensis Field Strains
Label-free proteomic analyses involving trypsin digestion, separation of peptides by liquid
chromatography (LC) coupled to electrospray ionization, and peptide analysis applying mass
spectrometry revealed proteome level differences between B. abortus and B. melitensis field strains.
Figure 1 illustrates the heat map and the hierarchical clustering of the 828 proteins identified in at least
three of the six replicates for B. abortus and for B. melitensis. The volcano plot displays the negative log10
t-test p value over the log2 fold change. Proteins with p values above the dotted line (p < 0.05) were
considered to be differentially expressed between the two Brucella species. Initially the two species
differed in the expression of 568 proteins (t-test significance); upon application of a 1% false discovery
rate (FDR) filter [10] the intensities of 402 proteins were still found to be significantly different between
B. abortus and B. melitensis. Of note, 63 of these were found exclusively in the B. abortus and 103
exclusively in the B. melitensis field strain. The complete list of identified proteins is given in the
supplementary table (Supplementary Table S1, sheets 1–4).
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Figure 1. Brucella field strain proteome. (A) Heat map and hierarchical clustering of 828 
quantified proteins from 6 replicates of each field strain; (B) Volcano plot comparing the field strains 
of B. abortus and B. melitensis. The p-values were calculated by unpaired t-test analysis using log2 
transformed peptide intensities. Multiple testing correction was applied [10]. 
2.2. Immunoreactive Proteins of B. abortus 
A total of 50 immunoreactive protein spots, corresponding to different 25 proteins, were 
detected by two dimensional electrophoresis -immunoblotting with a cell lysate from a B. abortus field 
strain and sera from naturally infected cows, buffaloes, sheep, and goats (Figure 2). Total numbers of 
proteins identified were 24, 19, 29, and 15 for cow, buffalo, sheep, and goat, respectively. Subsequent 
Western blot matching revealed 10 spots (A01–05, A15, A26, A47, A49, A50) (bold highlighted in 
Table 1), which corresponded to five proteins detected in the tested sera from all four naturally 
infected animal species. There was no unique host-specific immunodominant protein for buffalo and 
goat, whereas two (A43; A21) and four proteins (A08; A10, A11, A12) were specific for cow and sheep, 
respectively (Table 1). 
Figure 1. Brucella field strain proteome. (A) Heat map and hierarchical clustering of 828 quantified
proteins from 6 replicates of each field strain; (B) Volcano plot comparing the field strains of B. abortus
and B. melitensis. The p-values were calculated by unpaired t-test analysis using log2 transformed
peptide intensities. Multiple testing correction was applied [10].
2.2. Immunoreactive Proteins of B. abortus
A total of 50 immunoreactive protein spots, corresponding to different 25 proteins, were detected
by two dimensional electrophoresis -immunoblotting with a cell lysate from a B. abortus field strain
and sera from naturally infected cows, buffaloes, sheep, and goats (Figure 2). Total numbers of proteins
identified were 24, 19, 29, and 15 for cow, buffalo, sheep, and goat, respectively. Subsequent Western
blot matching revealed 10 spots (A01–05, A15, A26, A47, A49, A50) (bold highlighted in Table 1), which
corresponded to five proteins detected in the tested sera from all four naturally infected animal species.
There was no unique host-specific immunodominant protein for buffalo and goat, whereas two (A43;
A21) and four proteins (A08; A10, A11, A12) were specific for cow and sheep, respectively (Table 1).
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Figure 2. Representative two dimensional electrophoresis immunoblotting images of whole cell 
proteins from B. abortus field strain extracts separated on a 12% polyacrylamide gel. The blot was 
developed using the TMB (3,3′,5,5′-tetramethylbenzidine liquid substrate) kit after immuno-blotting 
with serum from (A) cattle; (B) buffalo; (C) sheep; and (D) goat and the respective peroxidase-
conjugated secondary antibodies. 
Repr sen ative two dimensional electrophoresis immun blotting images of whole
cell proteins from B. abortus field strain extracts s parated on a 12% polyacrylamide ge . The
blot was developed using the TMB (3,31,5,51-tetramethylbenzidine liquid substrate) kit after
immuno-blotting with serum from (A) cattle; (B) buffalo; (C) sheep; (D) goat and the respective
peroxidase-conjugated secon ary antibodies.
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Table 1. Immunoreactive proteins from Brucella (B.) abortus using two dimensional electrophoresis Western blot and Matrix-assisted laser desorption/ionization-Tine
of Flight-Mass Spectrometry (MALDI-TOF-MS). Spot ID: Spot identification; A: B. abortus; M: B. melitensis; Acc.ID: Accession number at the National Center for
Biotechnology Information (NCBI) databank; Proteins: Description as in the NCBI database and the bold highlighted proteins were those considered as a promising
candidate for future sero-diagnostics assays; Mw: Molecular weight; MOlecular Weight Search (MOWSE) score: ´10*Log (p), where p is the probability that the
observed match is a random event. This list includes only bands with a MOWSE score greater than (p <0.05); pI: Isoelectric point; Sequence coverage (%): Is the
percentage of peptide that covers the complete sequence of the protein; No. of peptides matching: Is the number of peptides that matched with the protein sequence.
No. SpotID Acc.ID Protein Mw MOWSE Score






A01 gi|256369084 Dihydrodipicolinate synthase 31,892 244 6.26 67 13 Cow, Buffalo,Sheep, Goat
A03 gi|256369084 Dihydrodipicolinate synthase 31,892 426 6.26 67 13 Cow, Buffalo,Sheep, Goat
A05 gi|493692811 Dihydrodipicolinate synthase 33,539 132 7.08 68 14 Cow, Buffalo,Sheep, Goat
A15 gi|495149454 Dihydrodipicolinate synthase 31,753 75 5.94 28 5 Cow, Buffalo,Sheep, Goat
2
A02 gi|496823699 Glyceraldehyde-3-phosphatedehydrogenase 36,385 356 6.26 48 13
Cow, Buffalo,
Sheep, Goat [10]
A04 gi|4165122 Glyceraldehyde-3-phosphatedehydrogenase 36,344 107 5.89 38 8
Cow, Buffalo,
Sheep, Goat [10]





29,383 343 5.09 36 7 Cow, Buffalo,Sheep, Goat M25
5
A49 gi|17987134 Phosphopyruvate hydratase 45,462 421 4.99 53 18 Cow, Buffalo,Sheep, Goat
A50 gi|148560469 Phosphopyruvate hydratase 45,431 494 5.03 47 16 Cow, Buffalo,Sheep, Goat
6 A20 gi|148558534 Metal-dependent hydrolase 25,257 103 5.58 44 7 Cow, Buffalo,Sheep
7 A17 gi|82700282 Choloylglycine hydrolase 36,868 108 5.62 29 9 Cow, Sheep,Goat
8
A22 gi|490830157 Hydrolase 27,731 134 6.07 50 8 Cow, Buffalo,Sheep [11] M43
A19 gi|490830157 Hydrolase 27,731 383 6.07 48 8 Cow, Buffalo,Sheep [11]
9 A44 gi|320161003 Putative DNA processing protein 40,919 56 5.85 42 7 Cow, Buffalo,Sheep
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No. SpotID Acc.ID Protein Mw MOWSE Score





10 A46 gi|489055332 2-Hydroxyhepta-2,4-diene-1,7-dioateisomerase 30,092 380 5.08 48 8
Cow, Buffalo,
Sheep
11 A41 gi|493691811 Sugar ABC transportersubstrate-binding protein 33,258 440 5.11 52 11
Cow, Buffalo,
Sheep M36
12 A45 gi|384211119 Lysine-arginine-ornithine-bindingperiplasmic protein 36,684 440 5.09 57 15 Cow, Buffalo M27
13 A48 gi|152013695 ADP/ATP translocase 20,876 63 9.63 31 4 Cow, Buffalo
14 A39 gi|62317242 Urocanate hydratase 61,589 173 6.04 19 11 Buffalo, Sheep
15 A24 gi|493147262 Sulfate transporter subunit 37,727 132 5.92 38 11 Cow, Sheep
16 A31 gi|493053174 Catalase 55,556 223 6.62 36 18 Cow, Goat
17 A40 gi|17988780 D-ribose-binding periplasmicprotein precursor 31,030 193 5.60 57 9 Cow, Sheep [12–14] M24
18
A29 gi|148558491 Chaperonin GroEL 57,505 99 5.08 18 7 Sheep, Goat [7,15–17]
A30 gi|14855849 Chaperonin GroEL 57,505 92 5.08 20 9 Sheep, Goat [7,15–17]
19 A32 gi|144108 Heat shock protein 57,534 94 5.33 27 12 Sheep, Goat
20 A43 gi|492987884 Protein grpE 24,883 128 4.70 40 12 Cow
21
A07 gi|384446825 Superoxide dismutase,copper/zinc binding protein 17,255 370 6.10 64 7 Sheep [7,16–18] M01
A8 gi|489058379 Superoxide dismutasecopper/zinc binding protein 18,205 242 6.24 54 5 Sheep [7,16–18]
22 A10 gi|17989230 19 kDa periplasmic protein 20,238 68 6.06 8 1 Sheep M05
23
A11 gi|222447132 Ferritin (bacterioferritin) 20,895 68 6.05 33 5 Sheep
A13 gi|222447132 Ferritin (bacterioferritin) 20,895 183 5.05 36 4 Sheep M12
24 A12 gi|493690773 Bacterioferritin, partial 16,118 220 4.81 33 3 Sheep [16,17]
25 A21 gi|89258175 31 kDa cell surface protein 31,084 293 5.50 38 9 Cow [16] M21
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2.3. Immunoreactive Proteins of B. melitensis
A total of 43 immunoreactive protein spots corresponding to 20 different proteins were identified
in the cell lysate of a B. melitensis field strain. Total numbers of proteins identified were 27, 19, 15, and
12 using sera from sheep, goat, cow, and buffalo, respectively (Figure 3). Subsequent Western blot
matching revealed 12 spots (M12; M19; M20; M24; M25; M26; M27; M36; M37; M38; M40; M22) (bold
highlighted in Table 2) common to all four tested animal species, corresponding to 10 proteins. There
was no unique host-specific immunodominant protein for buffalo and cow, whereas three (M32; M21;
M23) and six proteins (M01; M02; M05; M07; M08; M43) were specific for sheep and goat, and sheep
only (Table 2).
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Table 2. Immunoreactive proteins from B. melitensis using 2D-PAGE Western blot and MALDI-TOF-MS. Spot ID: Spot identification; A: B. abortus; M: B. melitensis;
Acc.ID: Accession number at NCBI; sequence in NCBI databank; Proteins: Description as in the NCBI database and the bold highlighted proteins were those considered
as a promising candidate for future sero-diagnostics assays; Mw: Molecular weight; MOWSE score: ´10*Log (p), where p is the probability that the observed match is
a random event. This list includes only bands with a MOWSE score greater than (p <0.05); pI: Isoelectric point; Sequence coverage (%): Is the percentage of peptide
that covers the complete sequence of the protein; No. of peptides matching: Is the number of peptides that matched with the protein sequence.
No. SpotID Acc.ID Protein Mw MOWSE Score





1 M12 gi|222447132 Ferritin (Bacterioferritin) 20,895 183 5.05 36 4 Sheep, Goat,Cow, Buffalo A13
2 M19 gi|225852817 Sulfate ABC transportersubstrate-binding protein 37,151 324 5.51 44 12
Sheep, Goat,
Cow, Buffalo
3 M20 gi|17986956 Thiosulfate-binding proteinprecursor 37,152 34 5.31 5 1
Sheep, Goat,
Cow, Buffalo
4 M24 gi|17988780 D-ribose-binding periplasmicprotein precursor 31,030 280 5.60 29 5
Sheep, Goat,
Cow, Buffalo [12–14] A40
5
M25 gi|225851771 Fumarylacetoacetate hydrolasedomain-containing protein 2 30,118 471 5.00 61 11
Sheep, Goat,
Cow, Buffalo A47
M26 gi|225851771 Fumarylacetoacetate hydrolasedomain-containing protein 2 30,118 492 5.00 56 11
Sheep, Goat,
Cow, Buffalo
6 M27 gi|384211119 Lysine-arginine-ornithine-bindingperiplasmic protein 36,684 240 5.09 31 10
Sheep, Goat,
Cow, Buffalo A45
7 M36 gi|516360216 Sugar ABC transportersubstrate-binding protein, partial 44,963 121 5.15 50 15
Sheep, Goat,
Cow, Buffalo A41
8 M37 gi|493172683 Amino acid ABC transportersubstrate-binding protein 31,331 178 5.24 48 7
Sheep, Goat,
Cow, Buffalo [16]
9 M40 gi|384410242 Amidohydrolase 3 63,567 265 5.47 42 20 Sheep, Goat,Cow, Buffalo
10
M22 gi|493003797
Hypothetical protein similar to
amino acid ABC transporter
substrate-binding protein
21,946 90 5.06 33 4 Sheep, Goat,Cow, Buffalo
M38 gi|493155701
Hypothetical protein similar to
ABC transporter
substrate-binding protein
58,947 437 4.97 43 24 Sheep, Goat,Cow, Buffalo
M32 gi|492818336
Hypothetical protein similar to
ABC transporter substrate-binding
protein
31,905 113 5.57 33 7 Sheep, Goat
11
M14 gi|490823297 Alcohol dehydrogenase 36,537 116 6.07 21 7 Sheep, Goat,Cow
M16 gi|489059662 Alcohol dehydrogenase 43,149 99 7.66 25 9 Sheep, Goat,Cow
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Table 2. Cont.
No. SpotID Acc.ID Protein Mw MOWSE Score









M21 gi|89258175 31 kDa cell surface protein 31,084 96 5.50 52 10 Sheep, Goat [16] A21
M30 gi|89258175 31 kDa cell surface protein 31,084 166 5.50 16 5 Sheep, Goat [16]
14 M23 gi|225686619 rhizopine-binding protein 33,294 257 5.11 55 11 Sheep, Goat
15
M01 gi|384446825 Superoxide dismutase,copper/zinc binding protein 17,255 222 6.10 51 6 Sheep [7,16–18] A07
M03 gi|384446825 Superoxide dismutase,copper/zinc binding protein 17,255 86 6.1 57 6 Sheep [7,16–18]
16
M02 gi|118137288 Copper/zinc superoxidedismutase 16,176 297 6.11 63 7 Sheep
M04 gi|551701922 Copper/zinc superoxidedismutase 16,176 83 6.11 61 6 Sheep
17 M05 gi|384446516 19 kDa periplasmic protein 18,735 219 5.65 20 4 Sheep A10
18 M07 gi|495782928 Transaldolase 23,554 264 5.47 41 8 Sheep [18]
19 M08 gi|493009465 Fructose-6-phosphate aldolase 23,554 244 5.47 22 5 Sheep
20 M43 gi|490830157 Hydrolase 27,731 371 6.07 48 8 Sheep A22
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2.4. Identification of Cross-Reactive Proteins between B. abortus and B. melitensis
The cell lysates of the B. abortus and B. melitensis field strains generated a total of 61
immunoreactive spots which could be assigned to 36 proteins. Nine proteins (A47/M25; A22/M43;
A41/M36; A45/M27; A40/M24; A07/M01; A10/M05; A13/M12; A21/M21) were detected in cell
lysates of B. abortus and B. melitensis (Table 3), while 16 and 11 proteins were only detected in cell lysates
of B. abortus or B. melitensis, respectively (Tables 1 and 2). Spot ID A47/M25 (fumarylacetoacetate
hydrolase domain-containing protein 2) was found in cell lysates of B. abortus and B. melitensis and
reacted with the sera of all four tested animal species (Tables 3 and 4). All immunogenic spots
reacted only with sera of Brucella-positive animals and no reactions were detected with sera from
Brucella-negative animals.
Table 3. Cross-reactive proteins identified by immunoblotting in the B. abortus and B. melitensis field
strains using sera from different naturally infected host species (A: B. abortus; M: B. melitensis); Acc.ID:
accession number at NCBI.
No. Acc.ID Protein
B. abortus B. melitensis
Spot ID Host Spot ID Host





2 gi|490830157 Hydrolase A22 Cow, Buffalo,Sheep M43 Sheep





4 gi|384211119 Lysine-arginine-ornithine-bindingperiplasmic protein A45 Cow, Buffalo M27
Cow, Buffalo,
Sheep, Goat
5 gi|17988780 D-ribose-binding periplasmicprotein precursor A40 Cow, Sheep M24
Cow, Buffalo,
Sheep, Goat
6 gi|384446825 Superoxide dismutase,copper/zinc binding protein A07 Sheep M01 Sheep
7 gi|384446516 19 kDa periplasmic protein A10 Sheep M05 Sheep
8 gi|222447132 Ferritin (Bacterioferritin) A13 Sheep M12 Cow, Buffalo,Sheep, Goat
9 gi|89258175 31 kDa cell surface protein A21 Cow M21 Sheep, Goat
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Table 4. Comparative Blast search between the identified proteins obtained from B. abortus and B. melitensis field strains and from proteins of putatively cross-reacting
bacteria (A: B. abortus; M: B. melitensis); low cross-reactivity % values are in bold text. Acc.ID: Accession number at NCBI; Y: Yersinia; S: Salmonella.
No. Spot ID Acc.ID Protein
Locus, Query Cover (QC) and Identity (I)
Host
100% Identity Brucella spp. B. suis B. ovis Ochrobactrum spp. Y. enterocolitica Y. pseudotuberculosis S. enterica E. coli O:157
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2.5. Comparative Basic Local Alignment Search Tool (BLAST) Analysis
In order to identify similar or identical epitope structures between Brucella spp., Ochrobactrum spp.
and putative cross-reacting bacterial species, five B. abortus proteins (spot ID A47; A01; A02; A26; A49)
and five B. melitensis proteins (spot ID M20; M37; M40; M22; M38) reacting with the sera of all four
naturally infected animal host species (i.e., cattle, buffalo, sheep, goat) were selected and submitted to
a comparative protein BLAST search (Table 4).
With the exception of the proteins (spot ID) A01, M22, M38, and M40, all proteins displayed
identity values ě95% for Brucella spp., B. suis, B. ovis and Ochrobactrum spp. Identity values of all
ten proteins with the possibly cross-reacting bacterial species Y. enterocolitica, Y. pseudotuberculosis,
S. enterica and E. coli O:157 were between 26% and 62%.
3. Discussion
Diagnosis of brucellosis in veterinary medicine is still a challenging process as it is based on
serology and isolation of the agent [6]. The serological assays have their limitations with regard to
sensitivity and specificity, moreover, they are not able to distinguish between infected and vaccinated
animals [19–21]. Hence, the aim of this study was to identify immunodominant proteins in a B. abortus
and a B. melitensis field strain by immunoproteomic screening to detect specific proteins for a future
diagnostic assay. Among the 61 proteins found to be immunoreactive, four proteins expressed in B.
abortus, five proteins expressed in B. melitensis cell lysates, and one protein present in both B. abortus
and B. melitensis cell lysates were identified as promising candidates for further analysis.
In contrast to previous studies on the Brucella proteome which focussed mainly on
vaccine or museum strains with altered immunogenic properties, i.e., diminished or loss of
virulence [3,7,12,14,16,19,22–24], the present study used a fully virulent B. abortus field strain and
a fully virulent B. melitensis field strain from a naturally infected cow and sheep, respectively. Sera
obtained from naturally infected ruminants which had recently aborted and shown strong positive
reactions in the RBT, CFT, and ELISA, were subsequently tested against both field strains. The strains
and sera used in the present study can therefore be expected to represent the acute phase of the disease.
Since naturally infected hosts generally show a stronger immunoreaction than hosts challenged with
inactivated antigen [7], it can be assumed that the sera used in the present study contained antibodies
against all immunoreactive proteins involved in infection.
In the present study LC/MS-based quantitative proteomic analysis revealed considerable
differences in protein expression in the two Brucella field strains. Based on these findings a 2D-PAGE
immunoblotting approach was used to determine immunodominant proteins in both field strains.
Several studies using two-dimensional gel electrophoresis and mass spectrometry were also able
to determine proteome level differences among the laboratory-grown strains B. abortus 2308 and
B. melitensis 16M and revealed a species-specific protein expression pattern [3,14].
The present study identified a total of 61 immunoreactive protein spots from the proteomic profiles
of B. abortus and B. melitensis using MALDI-TOF MS and the NCBI database search corresponding
to 36 proteins. When performing a data base search against the sequence information of all entries
in the NCBI database, the likelihood of identifying suitable proteins was significantly increased
by applying MS/MS matched to at least one unique peptide. This approach contrasts that of
Al-Dahouk et al., Yang et al. and Connolly et al., [7,12,16], who searched only against data sets
of the Brucella species used in their experiments, and Zhao et al. [22], who selected proteins containing
more than five peptide matches.
Each Brucella species can be associated with a specific host, i.e., B. abortus usually infects bovines,
whereas B. melitensis is the most predominant species in sheep and goat [5]. Despite the close
genetic relationship among Brucella spp. one could speculate that certain proteins induce a host
species-specific immunoreaction. This hypothesis is corroborated by the findings of Zhao et al. [22], who
demonstrated that some proteins are themselves immunogenic and induce high immunogenicity in the
host species but not in others. The sera obtained from sheep were the most reactive, with 56 identified
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immunogenic protein spots, whereas 39, 31, and 34 spots were found in the sera of cow, buffalo and
goat, respectively. Previous studies using the same immunoproteomic techniques as in the present
study identified a differing range of immunoreactive proteins in various Brucella spp. and animal
species [7,12,16,19,22,23]. These observed differences can be attributed to the technical procedures
during protein preparation and the source/type of sera samples used, i.e., field or experimental,
early or late stage of infection [23]. Moreover, these findings are indicative of a host
species-specific immunoreaction.
Ten immunogenic proteins specific either from B. abortus (n = 4), B. melitensis (n = 5) or both
(n = 1) were reactive with the sera of all four tested host species, i.e., cattle, buffalo, sheep, and goat. The
mitochondrial catalytic enzyme, fumarylacetoacetate hydrolase domain-containing protein (FAHD2)
was found in both B. abortus and B. melitensis cell lysates. To date, the role of this mitochondrial protein
in the pathogenesis of Brucella infections is not known. Four proteins were identified in B. abortus only,
i.e., dihydrodipicolinate synthase (DHDPS), glyceraldehyde-3-phosphate dehydrogenase (GAPDH),
lactate/malate dehydrogenase, and phosphopyruvate hydratase. DHDPS is essential for bacterial
growth and involved in the lysine biosynthesis pathway. This protein has been isolated from various
Gram positive and Gram negative bacteria and is considered to be an attractive antibiotic target [25].
GAPDH is a protein of the Brucella-containing vacuole (BCV) and essential for B. abortus virulence [26].
Studies using recombinant B. abortus derived GAPDH induced both humoral and cellular immune
responses during experimental infection with B. abortus in natural hosts (cattle and sheep) and mice [11].
However, when used as DNA vaccine it provided only partial protection against experimental B. abortus
infection in mice [11]. lactate/malate dehydrogenase from B. abortus is considered to be a promising
candidate for serodiagnosis and vaccine development due to its immunogenic characteristics [27], but
further studies are required. Phosphopyruvate hydratase proteins participate in glycolysis, but their
importance as possible diagnostic candidates is not known [28].
Five proteins found only in B. melitensis cell lysates were immunoreactive in all four host species:
thiosulfate-binding protein precursor, which specifically binds thiosulfate and is involved in its
transmembrane transport; amidohydrolase 3, a member of the amidohydrolase superfamily. These
proteins catalyse the hydrolysis of amide or amine bonds in a large number of different substrates [29].
Amino-acid ABC transporter substrate-binding protein, a transmembrane protein previously found
via proteome analysis in B. melitensis and B. ovis [30], and two hypothetical proteins closely related to
the ABC transporter substrate-binding proteins. The function of these differentially expressed proteins
in natural B. melitensis infection is not known to date.
LPS is the major cell surface antigen of Brucella and one of the main reasons for
serological cross-reactions with other Gram-negative bacteria such as E. coli, Salmonella spp., and
Y. enterocolitica [7,21,31]. LPS has been shown to bind to sodium dodecyl sulfate (SDS), and may
mimic protein spots in SDS polyacrylamide gels [32,33]. LPS closely associates with the protein and
traces of LPS are expected to be present in the whole cell protein extract irrespective of the extraction
method used. In order to exclude the likelihood of LPS interference during immunostaining, the
LPS concentration was measured in the extract. The whole cell protein extracts of B. abortus and
B. melitensis contained 0.9 and 100 ng/mL of LPS, respectively. This LPS concentration is below the
limit of detection of monoclonal antibodies [34] and therefore any interference of LPS can be excluded.
BLAST search to assess the similarity of these immunoreactive proteins identified among
several Brucella species and possibly cross-reacting bacteria revealed that by combining various
proteins it is possible to design a pan-Brucella test as well as a species-differentiating assay.
Glyceraldehyde-3-phosphate dehydrogenase, lactate/malate dehydrogenase, thiosulfate-binding
protein precursor, the amino acid ABC transporter substrate-binding proteins, and FAHD2 are suitable
candidates for designing a pan-Brucella test. Aminohydrolase 3 on the other hand, might be useful for
the differentiation of B. ovis and Ochrobactrum spp. from B. abortus, B. melitensis, and B. suis.
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4. Materials and Methods
4.1. Bacterial Strains and Sera Selection
The strains and sera used in the present study were obtained from the Friedrich-Loeffler-Institut
(FLI), Federal Research Institute for Animal Health, Institute of Bacterial Infections and Zoonoses, Jena,
Germany. The utilised Brucella field strains were isolated from an outbreak in Turkey (B. abortus; cow)
and an outbreak in China (B. melitensis; ewe). Identification and biotyping of these Brucella isolates was
carried out as previously described [6,35]. The serum samples were collected in Egypt from naturally
infected ruminants which had recently aborted (i.e., acute stage of infection); 35 sera were sent to the
FLI for further analysis. Sera were considered positive if the Rose Bengal test (RBT) showed strong
agglutination; the complement fixation test (CFT) showed more than 1000 sensE/mL; and the ELISA
an OD ě 3. For each animal species (i.e., cattle, buffalo, sheep, goat) three positive serum samples
were selected and used separately in the present study [6]. Negative serum samples were collected
from non-infected animals in a non-endemic region. Experiments were run in three replicates. No sera
could be obtained from the outbreaks in Turkey and China, and no isolates could be obtained from the
outbreak in Egypt.
4.2. Ethics Statement
The sera samples collected during routine diagnosis from Egypt were approved (no 11/2012) by
the Ethics committee at the Dean’s office, Faculty of Veterinary Medicine, Benha University, Ministry
of Higher Education, Qalyobia, Egypt. All further sera used in this study were samples originally
submitted for diagnostic purposes to and subsequently stored at FLI. According to German law,
ethical approval or special permission concerning animal welfare is not required for sera meant for
diagnostic purposes.
4.3. Cell Culture and Protein Extraction
Whole cell protein of the B. abortus and B. melitensis field strains was extracted as described
previously [36]. The strains were cultured in Tryptic Soy media for 48 h at 37 ˝C; bacteria were
harvested by centrifugation, washed twice with phosphate buffer saline, spun down, and the resulting
pellets resuspended in 80% ethanol (v/v). Following centrifugation, the ethanol was discarded
and the cell pellet air dried to ensure the removal of traces of ethanol. The cell pellets were then
resuspended in 250 µL of HEPES buffer (20 mM, pH 7.4) and sonicated (duty cycle: 1.0, amplitude:
100%, UP100H; Hielscher Ultrasound Technology, Teltow, Germany) for 45 s on ice. After centrifugation
at 11,290ˆ g for 10 min at 4 ˝C, the clear supernatant was collected. The protein content was determined
using the modified Bradford method (Bio-Rad, München, Germany) [37]. The concentration of
LPS was determined as concentration of endotoxin using the recombinant factor C fluorescence
assay (Haemotox rFC Haemochrom Diagnostica GmbH, Essen, Germany). The sample was spiked
with an endotoxin standard (PPC-Spike) and LPS determination was carried out according to the
manufacturer’s instructions.
4.4. In-Solution Trypsin Digestion
Ten µg of the protein extract (B. abortus and B. melitensis) were acetone precipitated and
reconstituted in 20 µL of denaturation buffer (6 M urea/2 M thiourea in 10 mM HEPES, pH 8.0).
The following steps were carried out with incubation steps at room temperature and gentle shaking.
Reduction of disulfide bridges was performed by adding 0.2 µL of 10 mM dithiothreitol in 50 mM of
ammonium bicarbonate (ABC) and incubation for 30 min, followed by an alkylation step with 0.4 µL
of 55 mM iodacemtamide in ABC and incubation in the dark for 20 min. Then 0.4 µL of LysC (Sigma,
Taufkirchen Germany) solution (0.5 µg/µL in ABC) was added and subjected to overnight incubation
at RT. After pre-digestion with LysC, the sample was diluted by adding 75 µL of ABC to bring down
the urea concentration to <2 M and digestion was started by adding 0.4 µL of 0.5 µg/µL trypsin in
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50 mM ABC. Following overnight incubation, trypsin activity was stopped by adding 100 µL of 5%
acetonitrile in 3% trifluoroacetic acid.
4.5. Liquid Chromatography-Electrospray Ionization-Tandem Mass Spectrometry (LC-ESI-MS/MS)
After digestion peptide samples were desalted by solid phase extraction (SPE), using C18 stage
tips [38]. Desalted peptide mixtures were separated by reverse-phase chromatography using a Dionex
Ultimate 3000 nanoLC on in-house manufactured 25 cm fritless silica microcolumns with an inner
diameter of 100 µm. Columns were packed with ReproSil-Pur C18-AQ 3 µm resin (Dr. Maisch
GmbH, Ammerbuch-Entringen, Germany). Peptides were separated on a 5%–60% acetonitrile gradient
with 0.1% formic acid at a flow rate of 350 nL/min for 90 min. Eluting peptides were ionized
on-line by electrospray ionization and transferred into an LTQ Orbitrap Velos mass spectrometer
(Thermo Fisher Scientific, Bremen, Germany). The LTQ-Orbitrap was operated in the positive mode
to simultaneously measure full scan MS spectra (from m/z 300–1700) in the Orbitrap analyzer at
resolution R = 60,000 following isolation and fragmentation of the twenty most intense ions in the LTQ
part by collision-induced dissociation.
4.6. Protein Identification and Data Analysis
A freely available software suit, MaxQuant (version. 1.3.0.5) (Max-Planck-Institute of Biochemistry,
Martinsried, Germany) was used to process the raw MS files and the search engine, Andromeda [39]
was utilized to search the peak list files against forward and backward protein sequences of Brucella
(Reference proteome Brucella abortus (strain 2308) with protein count of 3022 and Brucella melitensis
(strain M28) with a protein count of 3351) downloaded from Uniprot database and 248 frequently
observed laboratory contaminants (accession date: August 2015). Initial maximum precursor and
fragment mass deviations were set to 7 ppm and 0.5 Da, respectively. Methionine oxidation/acetylation
of peptide N-termini and cysteine carbamidomethylation were set as variable and fixed modification,
respectively, for the search. Furthermore, enzyme specificity was set to trypsin and a maximum of two
missed cleavages was allowed for searching. The target-decoy-based false discovery rate (FDR) for
peptide and protein identification was set to 1% for peptides and proteins and the minimum peptide
length was set to 7 amino acids. Precursor mass tolerance was set to 20 ppm. The mass tolerance for
fragment ions was set to 0.5 Da. MS-quantification of proteins was performed using the label-free
quantification algorithm of the MaxQuant software package (Max-Planck-Institute of Biochemistry,
Martinsried, Germany) [40].
The statistical analysis was performed by unpaired Student´s t Test using the Perseus software [41]
version 1.4.1.3 package (Max-Planck-Institute of Biochemistry, Martinsried, Germany). For FDR
ccorrections of the significant p-values (p <0.05) the Benjamini-Hochberg procedure [10] was applied.
Heat map and volcano plots were calculated for further assessment and visualization.
4.7. Two-Dimensional Electrophoresis
Two-dimensional electrophoresis (2D-PAGE) was performed as described [42]. Briefly, the first
dimension of 2D-PAGE was performed by applying 100 µg of acetone-precipitated protein per sample
to pI, 4–7, 7.0 cm immobilized pH gradient (IPG) strips (Immobiline™ Dry Strip, GE Healthcare
Bio-sciences AB; Uppsala, Sweden). The strips were rehydrated overnight at room temperature with
135 µL DeStreak Rehydration Solution. Isoelectric focusing (IEF) was performed by using the Ettan™
IPGphor3™ Unit (GE Healthcare Europe; Freiburg, Germany) and carried out at 20 ˝C for 6.5 h at
5000 V and 50 µA/strip.
Then the strips were sequentially equilibrated for 20 min in 2 mL equilibration buffer 1 (0.05 M
trichloroethylene HCl (pH 8.8), 6 M urea, 30% glycerol, 4% SDS, 2% DTE, 0.002% bromophenol blue)
and equilibration buffer 2 (0.05 M trichloroethylene HCl (pH 8.8), 6 M urea, 30% glycerol, 4% SDS,
2.5% iodoacetamid, 0.002% bromophenol blue). Standard molecular weight prestained protein ladder
marker (10–250 kDa; Page Ruler™ Plus, ThermoScientific; Germany) and IPG strips were loaded
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onto homogeneous 12% polyacrylamide gels and sealed with 1% agarose solution. Electrophoresis
was carried out at room temperature and 10 mA/gel until the tracking dye reached the bottom of
the gels (1.5 h). 2D-PAGE protein profiles were visualized using Coomassie blue stain as previously
described [43].
4.8. 2-D-PAGE Western Blotting
2D-PAGE Immunoblotting was carried out as previously described [19,36] with minor
modifications. Briefly, proteins were separated on 2D-PAGE gels and transferred at 80 mA/gel
for 90 min to nitrocellulose membranes (0.2 µM Bio-Rad laboratories; München, Germany) using
Towbin transfer buffer (0.025 M Tris, 0.192 M glycine, 2.33% SDS, 20% (v/v) methanol, pH 8.3). The
nitrocellulose membrane was blocked overnight at room temperature with gentle shaking in 1%
skimmed milk in Tris buffered saline (TBS). The membrane was washed twice using TBS with Tween
(TBST; 20 mM Tris, pH 7.5; 500 mM NaCl; 0.05% Tween-20; 10 min). Next, the nitrocellulose membrane
was placed for 90 min at room temperature in a diluted solution of the respective sera in TBST. Bovine
sera (1:200 dilution) and small ruminants sera (1:5000 dilution) were used as primary antibody source
while 1:1000 diluted anti-bovine IgG (H and L) (Chicken) peroxidase-conjugated, anti-sheep IgG (H
and L) (Donkey) peroxidase-conjugated and anti-goat IgG (H and L) (Chicken) peroxidase-conjugated
antibody served as secondary antibody source. All the secondary antibodies were obtained from
Biomol-Rockland, Hamburg, Germany. After washing the nitrocellulose membrane twice with TBST
for 10 min, the detection of signals was carried out using the TMB kit™ (3,31,5,51-tetramethylbenzidine
liquid substrate; Sigma-Aldrich; Steinheim, Germany) according to the manufacturer’s description.
4.9. In-Gel Trypsin Digestion and Matrix-Assisted Laser Desorption/ionization-Tine of Flight-Mass
Spectrometry (MALDI-TOF MS/MS)
Following the selection of the spots of interest, i.e., spots detected in all three replicates,
the protein spots corresponding to the Western blots were excised from the gel, destained, and
subjected to overnight trypsin digestion (0.01 µg/µL) (Promega; Mannheim, Germany) as previously
described [44]. The digested precipitates were reconstituted in 3.5 µL 5% acetonitrile in 0.1% TFA
(trifluoroacetic acid; Merck; Darmstadt, Germany). The reconstituted precipitates were then spotted
on to target plates for matrix-assisted laser desorption/ionization-time-of-flight mass spectrometry
(MALDI-TOF MS) on a Bruker Ultraflex II instrument (Bruker Daltonik; Bremen, Germany) using
HCCA (α-cyano-4-hydroxycinnamic acid; Sigma-Aldrich; Steinheim, Germany) as matrix. A
database search was conducted against all entries using the MS/MS ion search mode (MASCOT,
http://www.matrixscience.com) as previously described [36]. Protein identification was considered
valid if more than two peptides matched and the MOWSE score was significant (p < 0.05).
4.10. Comparison of the Identified Proteins and Other Cross-Reactive Bacteria
BLAST search was done as previously described [3] to compare the identified proteins against
Brucella spp., B. suis, B. ovis, Ochrobactrum spp., Y. enterocolitica, Y. pseudotuberculosis, S. enterica, and
E. coli O:157, the latter five species being the most cross-reactive bacteria with Brucella. Query cover
and identity values were evaluated and cut-off values set between 31%–54%.
5. Conclusions
The sera from naturally infected host species appear to possess different antibodies against
B. abortus and B. melitensis. The presence of specific antibodies against four proteins of
B. abortus, fumarylacetoacetate hydrolase 2, dihydrodipicolinate synthase, glyceraldehyde-3-phosphate
dehydrogenase, and lactate/malate dehydrogenase as well as one protein from B. melitensis, ABC
transporter substrate-binding protein, indicates that these proteins might be useful for designing a
serology-based assay for the rapid species determination of Brucella. As suggested earlier, these results
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should be further verified using bacterial strains and sera collected from various geographical regions
and sera from a variety of host species.
Cross-reactivity with other Gram negative bacteria and within the species of the genus is the
major hindrance for the serological diagnosis of brucellosis. The results presented here open up new
possibilities for the serodiagnosis of brucellosis by providing Brucella species-specific immunodominant
protein candidates reacting only with sera collected from naturally infected cattle, buffaloes, sheep,
and goats. The study provides information on new protein candidates and could help to improve the
serological diagnosis of brucellosis.
Supplementary Materials: Supplementary materials can be found at http://www.mdpi.com/1422-0067/17/5/
659/s1.
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